Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mommeja-Marin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 5, 2005
Posttreatment exacerbation of hepatitis B virus (HBV) infection in long-term HBV trials of emtricitabineE Mondou, J Sorbel, J Anderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 1998
Facial folliculitis due to Clostridium perfringens in a patient infected with human immunodeficiency virusE Caumes, H Mommeja-Marin, O Chosidow, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Anaphylactic reaction after a first filgrastim (granulocyte-colony stimulating factor) injectionL Batel-Copel, H Mommeja-Marin, S Oudard, et al.
La Revue De Medecine Interne|December 17, 2002
[Dysarthria during irinotecan administration]B Ceccaldi, F Kara, H Mommeja-Marin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 29, 1998
Indinavir crystal deposits associated with tubulointerstitial nephropathyF Martinez, H Mommeja-Marin, L Estepa-Maurice, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 3, 2016
Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised hostK M Mullane, C Nuss, J Ridgeway, et al.
Alimentary Pharmacology & Therapeutics|March 28, 2008
Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis BS G Lim, N Leung, H W L Hann, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 5, 2005
Posttreatment exacerbation of hepatitis B virus (HBV) infection in long-term HBV trials of emtricitabineE Mondou, J Sorbel, J Anderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 1998
Facial folliculitis due to Clostridium perfringens in a patient infected with human immunodeficiency virusE Caumes, H Mommeja-Marin, O Chosidow, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Anaphylactic reaction after a first filgrastim (granulocyte-colony stimulating factor) injectionL Batel-Copel, H Mommeja-Marin, S Oudard, et al.
La Revue De Medecine Interne|December 17, 2002
[Dysarthria during irinotecan administration]B Ceccaldi, F Kara, H Mommeja-Marin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 29, 1998
Indinavir crystal deposits associated with tubulointerstitial nephropathyF Martinez, H Mommeja-Marin, L Estepa-Maurice, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 3, 2016
Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised hostK M Mullane, C Nuss, J Ridgeway, et al.
Alimentary Pharmacology & Therapeutics|March 28, 2008
Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis BS G Lim, N Leung, H W L Hann, et al.
Pageof 1